Skip to main content
. Author manuscript; available in PMC: 2018 Jan 12.
Published in final edited form as: Eur Respir J. 2016 Nov 11;48(6):1612–1621. doi: 10.1183/13993003.00524-2016

Table 1.

Subject Demographics

Discovery Set AREST CF Set
n (subjects) = 20 34
n (BALF) = 20 84
Age (years) 2.9±1.3 (0.48–4.95) 3.5±1.5 (0.96–5.83)
% Male 55% 43%
BMI (Z-score) 0.1±1.1 0.0±1.8
Treatment, hypertonic saline 6% 15%
Treatment, dornase alpha 3% 35%
Treatment, amoxicillin/clavulanate 48% 0%
Cell count (×106 cells/ml) 2.8±3.7 (0.18–12.94) 0.7±0.3 (0.06–1.67)
% PMNs 48.8±27.2 (2.5–93) 20.2±23.9 (0.67–92)
% with Pathogens 60% 17%
% with Staphylococcus 25% 7%
% with Pseudomonas 25% 2%

BALF = bronchoalveolar lavage fluid; PMNs = neutrophils